肝肠内引流术在肝门胆管癌外科治疗的应用  

Arch form hepatectomy with hepatojejunal internal drainage in surgical treatment of unresectable hilar cholangiocarcinoma

作　　者：许宝来[1] 路芳[1] 吴金术[2] 张连新 

机构地区：[1]武警广东总队医院外一科,广州510507 [2]湖南省人民医院肝胆外科,长沙410000 [3]广东省韶关市第一人民医院外科,韶关512000

出　　处：《武警医学》2004年第9期658-661,共4页Medical Journal of the Chinese People's Armed Police Force

摘　　要：目的探讨对无法切除的肝门胆管癌行肝肠内引流术的减黄效果和术式优点。方法对不能切除的Ⅲ、Ⅳ型肝门胆管癌在肝周边部作肝组织的拱形切除,行多肝段肝肠内引流术。结果术后1周总胆红素、谷丙转氨酶、碱性磷酸酶明显下降,患者术后平均生存期13.26个月。未发生与本操作有关的并发症。结论肝肠内引流术疗效满意,操作简便,并发症少,是治疗Ⅲ、Ⅳ型肝门胆管癌行之有效的方法。Objective To study the effectiveness of hepatojejunal internal drainage in reducing jaundice and the advantage of the operation for unresectable hilar cholangiocarcinoma.Methods A arch form excision of the edges of multiple hepatic segments followed by hepatojejunal internal drainage operation to drain the multiple hepatic ducts was used to treat unresectable stage Ⅲ、Ⅳ hilar cholangiocarcinoma.Results Total bilirubin,GPT,and AKP levels 7 days postoperation were significantly lower than those preoperation,and the mean survival time was 13.26 months.There was no operation death in the series.There was no complication related to this maneuver.Conclusion The technique is safe,simple,and few in complications;it is feasible and effective for unresectable stage Ⅲ,Ⅳ hilar cholangiocarcinoma.

关 键 词：内引流术 肝门胆管癌 并发症 不能切除 术后 外科治疗 总胆红素 结论 方法 目的 

分 类 号：R735.8[医药卫生—肿瘤] R657[医药卫生—临床医学]